Advancing cell and gene therapy impact

Advanced therapies are transforming science into hope. Cencora believes in the promise of these innovations to redefine what’s possible in healthcare, and we’re committed to helping to turn that promise into real-world patient access.

Broad market view, sharp patient focus

It takes a closely aligned ecosystem to move advanced therapies from concept to commercialization to care. Positioned at the center of this ecosystem, Cencora connects developers, providers, and patients to foster collaboration throughout the CGT lifecycle—enabling both today’s innovations and tomorrow’s possibilities. 

How we support access

Thanks to our deep relationships across the healthcare industry, we understand where momentum builds, where complexity slows progress, and where readiness can create a measurable impact.

We use this insight to help fill gaps, improve experiences, and drive better outcomes for your patients, the people who matter most.  

What changes for the people waiting on a therapy

For the person waiting, scientific progress alone does not create access. A therapy must move through approval, coverage, site readiness, ordering, and delivery before it can be administered.

That is why coordination matters. Cencora helps connect the stakeholders, processes, and logistics that can support a more efficient path to care.

Stories and resources from the field

Stories from the developers, providers, patients, and Cencora experts advanced cell and gene therapies across the healthcare ecosystem. 

Table Talk: Beyond the breakthrough

Prognosis positive: Creating healthier futures one patient at a time

Why big-picture planning is key to execution across the CGT lifecycle

Cell and gene therapy support, by the numbers

30
FDA and EMA-approved CGTs supported by Cencora
29K+
global CGT shipments delivered annually
800+
US providers order CGTs through Cencora annually

Connecting support across the CGT ecosystem

For development and commercial planning

Regulatory affairs, market access strategy, pharmacovigilance, and channel strategy purpose-built for advanced therapies.

For logistics and warehousing

Cryogenic and temperature-controlled logistics through Cencora's network of 100+ 3PL facilities and transport stations. 

For providers and sites of care

Readiness evaluation, economic modeling, and execution support for health systems building cell and gene therapy programs.

Integrated support across the commercialization journey

For patients waiting on the promise of advanced therapies, progress depends on more than science alone. Cencora helps connect developers, providers, and patients across the therapy lifecycle.